While not entirely feasible, testing for TAFI, PAI-1, and tPA upon hospital admission in severe cases may be helpful in defining coagulopathy linked to COVID-19 and identifying individuals at risk of hypofibrinolysis and poorer clinical outcomes. Here, PLAT is linked to COVID-19.